1. Home
  2. SMTC vs ALKS Comparison

SMTC vs ALKS Comparison

Compare SMTC & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Semtech Corporation

SMTC

Semtech Corporation

HOLD

Current Price

$125.88

Market Cap

9.6B

Sector

Technology

ML Signal

HOLD

Logo Alkermes plc

ALKS

Alkermes plc

HOLD

Current Price

$51.72

Market Cap

8.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMTC
ALKS
Founded
1960
1987
Country
United States
Ireland
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
8.7B
IPO Year
2002
2012

Fundamental Metrics

Financial Performance
Metric
SMTC
ALKS
Price
$125.88
$51.72
Analyst Decision
Strong Buy
Buy
Analyst Count
15
14
Target Price
$93.20
$43.43
AVG Volume (30 Days)
3.5M
2.3M
Earning Date
05-26-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
79.65
N/A
EPS
0.27
N/A
Revenue
$1,049,975,000.00
$1,475,899,000.00
Revenue This Year
$20.10
$24.26
Revenue Next Year
$13.01
$4.47
P/E Ratio
$466.85
N/A
Revenue Growth
15.47
N/A
52 Week Low
$46.02
$25.17
52 Week High
$177.35
$55.67

Technical Indicators

Market Signals
Indicator
SMTC
ALKS
Relative Strength Index (RSI) 41.64 59.89
Support Level $122.89 $27.78
Resistance Level $174.91 $55.67
Average True Range (ATR) 9.40 1.70
MACD -2.05 -0.62
Stochastic Oscillator 24.01 30.95

Price Performance

Historical Comparison
SMTC
ALKS

About SMTC Semtech Corporation

Semtech Corp is a provider of high-performance semiconductors powering data center networking, Internet of Things ("IoT") connectivity, and cellular infrastructure solutions. The company designs, develops, manufactures, and markets a diverse portfolio of products for commercial applications, addressing the infrastructure, high-end consumer, and industrial end markets. The company operates in four reportable segments: Signal Integrity, Analog Mixed Signal and Wireless, IoT Systems, and Connected Services. The majority of the company's revenue is earned through the Analog Mixed Signal and Wireless segment. Geographically, the majority of the company's revenue is earned from the Asia Pacific region; the company also operates in North America and Europe.

About ALKS Alkermes plc

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Share on Social Networks: